{"id":"NCT02287584","sponsor":"Sumitomo Pharma Co., Ltd.","briefTitle":"Confirmatory Study of DSP-5423P in Patients With Schizophrenia","officialTitle":"Confirmatory Study of DSP-5423P in Patients With Schizophrenia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12","primaryCompletion":"2018-12","completion":"2018-12","firstPosted":"2014-11-10","resultsPosted":"2020-12-23","lastUpdate":"2022-04-12"},"enrollment":580,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Schizophrenia"],"interventions":[{"type":"DRUG","name":"DSP-5423P Placebo","otherNames":[]},{"type":"DRUG","name":"DSP-5423P 40mg","otherNames":[]},{"type":"DRUG","name":"DSP-5423P 80mg","otherNames":[]},{"type":"DRUG","name":"DSP-5423P Placebo-to-Flex","otherNames":[]},{"type":"DRUG","name":"DSP-5423P Active-to-Flex","otherNames":[]}],"arms":[{"label":"DSP-5423P Placebo","type":"PLACEBO_COMPARATOR"},{"label":"DSP-5423P 40mg","type":"EXPERIMENTAL"},{"label":"DSP-5423P 80mg","type":"EXPERIMENTAL"},{"label":"DSP-5423P Placebo-to-Flex","type":"EXPERIMENTAL"},{"label":"DSP-5423P Active-to-Flex","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study is to evaluate the efficacy of DSP-5423P compared with placebo in patients with schizophrenia.","primaryOutcome":{"measure":"Change in PANSS Total Score From Baseline at Week 6","timeFrame":"Week 6","effectByArm":[{"arm":"DSP-5423P Placebo","deltaMin":99.5,"sd":13.84},{"arm":"DSP-5423P 40mg","deltaMin":101.6,"sd":15.55},{"arm":"DSP-5423P 80mg","deltaMin":101.5,"sd":14.76}],"pValues":[{"comp":"OG000 vs OG001","p":"0.007"},{"comp":"OG000 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":8,"countries":["China","Japan","Malaysia","Philippines","Russia","South Korea","Taiwan","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":190},"commonTop":["Akathisia","Tremor","Insomnia","Application site erythema","Nasopharyngitis"]}}